Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of single combined (long‐ or short‐acting beta₂ agonist plus an inhaled corticosteroid (ICS)) inhaler only used as needed in people with mild asthma.
Main Authors: | Crossingham, I, Turner, S, Ramakrishnan, S, Hynes, G, Gowell, M, Yasmin, F, Fries, A, Chaudhry, A, Hinks, TSC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2020
|
Similar Items
-
Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
by: Crossingham, I, et al.
Published: (2021) -
Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
by: Crossingham, I, et al.
Published: (2021) -
Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
by: McKeever, T, et al.
Published: (2018) -
Pharmacokinetic optimisation of inhaled steroid therapy in asthma.
by: Pavord, I, et al.
Published: (1993) -
Beta 2-agonists in asthma.
by: Britton, J, et al.
Published: (1991)